{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:20:55Z","timestamp":1790295655434,"version":"4.1.0"},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,11,15]]},"DOI":"10.2169\/internalmedicine.9415-22","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T22:11:20Z","timestamp":1649455880000},"page":"3445-3448","source":"Crossref","is-referenced-by-count":5,"title":["Anti-nuclear Matrix Protein 2 Antibody-positive Dermatomyositis Associated with Cervical Cancer Recurrence after 6 Years of Stable Disease"],"prefix":"10.2169","volume":"61","author":[{"given":"Takeshi","family":"Suga","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Hiroshima City Hiroshima Citizens Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Oiwa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hiroshima City Hiroshima Citizens Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yang H, Peng Q, Yin L, et al. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. Arthritis Res Ther 19: 259, 2017.","DOI":"10.1186\/s13075-017-1469-8"},{"key":"2","unstructured":"2. Oddis CV, Fertig N, Goel A, et al. Clinical and serological characterization of the anti-MJ antibody in childhood myositis [abstract]. Arthritis Rheum 40: S139, 1997."},{"key":"3","unstructured":"3. Targoff IN, Trieu EP, Levy-Neto M, Fertig N, Oddis CV. Sera with autoantibodies to the MJ antigen react with NXP2 [Abstract]. Arthritis Rheum 56: S787, 2007."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Albayda J, Pinal-Fernandez I, Huang W, et al. Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients. Arthritis Care Res (Hoboken) 69: 1771-1776, 2017.","DOI":"10.1002\/acr.23188"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ichimura Y, Konishi R, Shobo M, et al. Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash. Rheumatology (Oxford) 61: 1222-1227, 2022.","DOI":"10.1093\/rheumatology\/keab518"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bohan A, Peter JB. Polymyositis and dermatomyositis. I. N Engl J Med 292: 344-347, 1975.","DOI":"10.1056\/NEJM197502132920706"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bohan A, Peter JB. Polymyositis and dermatomyositis. II. N Engl J Med 292: 403-407, 1975.","DOI":"10.1056\/NEJM197502202920807"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bunch WT. Prednisone and azathioprine for polymyositis: long-term followup. Arthritis Rheum 24: 45-48, 1981.","DOI":"10.1002\/art.1780240107"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rogers A, Chung L, Li S, Casciola-Rosen L, Fiorentino DF. Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients. Arthritis Care Res (Hoboken) 69: 1909-1914, 2017.","DOI":"10.1002\/acr.23210"},{"key":"10","unstructured":"10. Ogawa-Momohara M, Muro Y, Mitsuma T, et al. Strong correlation between cancer progression and anti-transcription intermediary factor 1\u03b3 antibodies in dermatomyositis patients. Clin Exp Rheumatol 36: 990-995, 2018."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ichimura Y, Matsushita T, Hamaguchi Y, et al. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis 71: 710-713, 2012.","DOI":"10.1136\/annrheumdis-2011-200697"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/22\/61_9415-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T03:21:20Z","timestamp":1668828080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/22\/61_9415-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":11,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9415-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"article-number":"9415-22"}}